PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,892 | +92.3% | 471,012 | +96.0% | 0.00% | +100.0% |
| Q2 2023 | $1,504 | +23.4% | 240,320 | -6.1% | 0.00% | 0.0% |
| Q1 2023 | $1,219 | -13.7% | 255,922 | +57.7% | 0.00% | 0.0% |
| Q4 2022 | $1,412 | -99.9% | 162,319 | -16.3% | 0.00% | -66.7% |
| Q3 2022 | $2,308,000 | +32.0% | 193,871 | +57.9% | 0.00% | +200.0% |
| Q2 2022 | $1,748,000 | +860.4% | 122,751 | +1309.5% | 0.00% | – |
| Q1 2022 | $182,000 | – | 8,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |